Biogen Inc. buy Morgan Stanley
Start price
05.09.23
/
50%
€248.40
Target price
05.09.24
€355.70
Performance (%)
-27.13%
End price
06.09.24
€181.00
Summary
This prediction ended on 06.09.24 with a price of €181.00. The prediction for Biogen Inc. disappointed with a performance of -27.13%. Morgan_Stanley has 50% into this predictionPerformance without dividends (%)
| Name | 1w | 1m | 1y |
|---|---|---|---|
| Biogen Inc. | -3.027% | -3.027% | 29.575% |
| iShares Core DAX® | 1,60 % | -7,45 % | 3,04 % |
| iShares Nasdaq 100 | -0,73 % | -1,86 % | 15,42 % |
| iShares Nikkei 225® | 1,30 % | -6,80 % | 34,31 % |
| iShares S&P 500 | -0,39 % | -2,34 % | 9,91 % |
Comments by Morgan_Stanley for this prediction
In the thread Biogen Inc. diskutieren
Biogen Inc. (NASDAQ: BIIB) had its price target raised by analysts at Morgan Stanley from $363.00 to $381.00. They now have an "overweight" rating on the stock.
Ratings data for BIIB provided by MarketBeat
In the thread Trading Biogen Inc.
Die von Morgan_Stanley gewählte maximale Laufzeit wurde überschritten